Incidence and risk of congestive heart failure in patients with renal and nonrenal cell carcinoma treated with sunitinib.

Richards CJ, Je Y, Schutz FA, Heng DY, Dallabrida SM, Moslehi JJ, Choueiri TK
J Clin Oncol. 2011 29 (25): 3450-6

PMID: 21810682 · DOI:10.1200/JCO.2010.34.4309

MeSH Terms (20)

Adult Aged Aged, 80 and over Antineoplastic Agents Carcinoma, Renal Cell Clinical Trials, Phase II as Topic Clinical Trials, Phase III as Topic Follow-Up Studies Heart Failure Humans Incidence Indoles Kidney Neoplasms Middle Aged Pyrroles Randomized Controlled Trials as Topic Risk Factors Sunitinib Survival Rate Treatment Outcome

Connections (1)

This publication is referenced by other Labnodes entities: